U.S. Respiratory Syncytial Virus Vaccines Market Size, Share, Trends, Growth, and Forecast, 2025 - 2032

Table of Content

1. Executive Summary
   1. U.S. Respiratory Syncytial Virus Vaccines Market Snapshot, 2025 and 2032
   2. Market Opportunity Assessment, 2025 - 2032, US$ Mn
   3. Key Market Trends
   4. Future Market Projections
   5. Premium Market Insights
   6. Industry Developments and Key Market Events
   7. PMR Analysis and Recommendations
2. Market Overview
   1. Market Scope and Definition
   2. Market Dynamics
      1. Drivers
      2. Restraints
      3. Opportunity
      4. Key Trends
   3. Macro-Economic Factors
      1. U.S. Sectorial Outlook
      2. U.S. GDP Growth Outlook
   4. COVID-19 Impact Analysis
   5. Forecast Factors - Relevance and Impact
3. Value Added Insights
   1. Product Adoption Analysis
   2. Disease Epidemiology
   3. Regulatory Landscape
   4. Porter’s Five Forces Analysis
   5. PESTLE Analysis
   6. Promotional Strategies, By Key Players
4. U.S. Respiratory Syncytial Virus Vaccines Market Outlook
   1. Key Highlights
      1. Market Size (US$ Mn) and Y-o-Y Growth
      2. Absolute $ Opportunity
   2. Market Size (US$ Mn) Analysis and Forecast
      1. Historical Market Size (US$ Mn) Analysis, 2019 - 2024
      2. Market Size (US$ Mn) Analysis and Forecast, 2025 - 2032
   3. U.S. Respiratory Syncytial Virus Vaccines Market Outlook: Drug
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Mn) Analysis, By Drug, 2019 - 2024
      3. Market Size (US$ Mn) Analysis and Forecast, By Drug, 2025 - 2032
         1. Palivizumab
         2. ABRYSVO (RSVpreF PF06928316)
         3. Arexvy - RSVPreF3 OA (GSK3844766A)
         4. mRESVIA (mRNA-1345)
         5. Janssen RSV Vaccine
         6. ResVax
         7. Nirsevimab (MEDI8897)
         8. MVA-BN RSV
      4. Market Attractiveness Analysis: Drug
   4. U.S. Respiratory Syncytial Virus Vaccines Market Outlook: Distribution Channel
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Mn), By Distribution Channel, 2019 - 2024
      3. Market Size (US$ Mn) Analysis and Forecast, By Distribution Channel, 2025 - 2032
         1. Institutional Sales
            1. Hospitals
            2. Specialty Clinics
            3. Academic and Research Institutes
         2. Retail Sales
            1. Retail Pharmacy
            2. Drug Stores
         3. Online Sales
      4. Market Attractiveness Analysis: Distribution Channel
5. Competition Landscape
   1. Market Share Analysis, 2024
   2. Market Structure
      1. Competition Intensity Mapping By Market
      2. Competition Dashboard
   3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
      1. Pfizer Inc.
         1. Overview
         2. Segments and Products
         3. Key Financials
         4. Market Developments
         5. Market Strategy
      2. Sanofi
      3. Merck Sharp & Dohme
      4. GlaxoSmithKline
      5. SOBI
      6. Johnson & Johnson
      7. Bavarian Nordic
      8. Novavax
      9. AstraZeneca
      10. Moderna, Inc.
      11. Codagenix Inc.
      12. Intravacc BV.
      13. Alphavax, Inc.
6. Appendix
   1. Research Methodology
   2. Research Assumptions
   3. Acronyms and Abbreviations